当前位置:首页 - 行情中心 - 尔康制药(300267) - 财务分析 - 现金流量表

尔康制药

(300267)

  

流通市值:44.66亿  总市值:64.77亿
流通股本:14.22亿   总股本:20.63亿

现金流量表

报告期2026-03-312025-12-312025-09-302025-06-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金239,409,879.331,148,869,063.321,166,866,554.16792,973,373.15
  收到的税费返还2,923,821.067,788,046.817,425,034.26,302,693.6
  收到其他与经营活动有关的现金21,066,912.82335,790,016.0925,800,325.686,472,954.01
  经营活动现金流入小计263,400,613.211,492,447,126.221,200,091,914.04805,749,020.76
  购买商品、接受劳务支付的现金172,747,428.58620,209,903.93769,801,663.55584,585,381.69
  支付给职工以及为职工支付的现金49,507,464.81152,239,583.9119,576,739.7983,903,371.54
  支付的各项税费15,908,780.0152,051,865.5637,401,990.0224,868,076.81
  支付其他与经营活动有关的现金35,155,081.66410,260,801.5261,626,673.3366,549,943.19
  经营活动现金流出小计273,318,755.061,234,762,154.91988,407,066.69759,906,773.23
  经营活动产生的现金流量净额-9,918,141.85257,684,971.31211,684,847.3545,842,247.53
二、投资活动产生的现金流量:
  收回投资收到的现金170,000,0001,110,000,000740,000,000340,000,000
  取得投资收益收到的现金323,244.33,775,387.983,331,200.042,898,851.97
  处置固定资产、无形资产和其他长期资产收回的现金净额15,672.971,737,885.731,362,974.331,167,927.99
  投资活动现金流入小计170,338,917.271,115,513,273.71744,694,174.37344,066,779.96
  购建固定资产、无形资产和其他长期资产支付的现金34,797,831.2163,980,195.38107,779,667.0754,007,926.19
  投资支付的现金170,000,0001,080,000,000825,000,000395,000,000
  投资活动现金流出小计204,797,831.21,243,980,195.38932,779,667.07449,007,926.19
  投资活动产生的现金流量净额-34,458,913.93-128,466,921.67-188,085,492.7-104,941,146.23
三、筹资活动产生的现金流量:
  吸收投资收到的现金750,000---
  取得借款收到的现金269,000,000671,337,821463,987,821220,000,000
  收到其他与筹资活动有关的现金86,000,000278,600,000228,600,000190,000,000
  筹资活动现金流入小计355,750,000949,937,821692,587,821410,000,000
  偿还债务支付的现金136,000,000597,700,000457,700,000387,700,000
  分配股利、利润或偿付利息支付的现金3,329,283.3311,092,503.999,430,610.045,542,786.08
  支付其他与筹资活动有关的现金173,739,273.36372,684,503.86258,597,451.5282,672,626.13
  筹资活动现金流出小计313,068,556.69981,477,007.85725,728,061.56475,915,412.21
  筹资活动产生的现金流量净额42,681,443.31-31,539,186.85-33,140,240.56-65,915,412.21
四、汇率变动对现金及现金等价物的影响-545,998.75-3,364,598.62-2,347,103.42-1,555,462.31
五、现金及现金等价物净增加额-2,241,611.2294,314,264.17-11,887,989.33-126,569,773.22
  加:期初现金及现金等价物余额584,223,288.95489,909,024.78489,909,024.78489,909,024.78
  期末现金及现金等价物余额581,981,677.73584,223,288.95478,021,035.45363,339,251.56
补充资料:
  净利润--399,311,259.91-28,810,557.54
  资产减值准备-356,982,143.17--1,908,417.18
  固定资产和投资性房地产折旧-151,579,107.31-76,223,717.64
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-151,579,107.31-76,223,717.64
  无形资产摊销-22,909,486.63-11,025,411.4
  长期待摊费用摊销-3,445,357.31-1,700,062.25
  处置固定资产、无形资产和其他长期资产的损失--313,748.98--323,099.98
  固定资产报废损失-572,037.41-251,262.87
  公允价值变动损失---2,979,757.81
  财务费用-8,385,944.34-6,158,392.89
  投资损失-18,168,794.63--2,896,732.49
  递延所得税-29,567,995.37-1,451,124.61
  其中:递延所得税资产减少-30,143,847.78-1,926,820.89
    递延所得税负债增加--575,852.41--475,696.28
  存货的减少-42,034,563.72--26,109,504.88
  经营性应收项目的减少-2,482,707.86--27,668,358.72
  经营性应付项目的增加-27,712,497.51-2,727,597.77
  其他--12,991,577.09--30,258,886.21
  现金的期末余额-584,223,288.95-363,339,251.56
  减:现金的期初余额-489,909,024.78-489,909,024.78
  现金及现金等价物的净增加额-94,314,264.17--126,569,773.22
公告日期2026-04-242026-04-232025-10-302025-08-28
审计意见(境内)标准无保留意见
TOP↑